Off with the label and on the Avastin bandwagon: Why now and how far

Indian Journal of Ophthalmology

Volumn 57, Issue 4, 2009, Pages 253-256

  Santhan Gopal, K S ^a  

^a Kamalanethralaya   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; BEVACIZUMAB; MONOCLONAL ANTIBODY; VASCULOTROPIN A;

DRUG ANTAGONISM; DRUG INDUSTRY; ETHICS; HUMAN; INDIA; LEGAL ASPECT; MEDICAL ETHICS; METHODOLOGY; OFF LABEL DRUG USE; OPHTHALMOLOGY; REVIEW;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; DRUG INDUSTRY; ETHICS, MEDICAL; HUMANS; INDIA; OFF-LABEL USE; OPHTHALMOLOGY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 68249153295     PISSN: 03014738     EISSN: 19983689     Source Type: Journal    
DOI: 10.4103/0301-4738.53048     Document Type: Review

References (13)

1. Rosenfeld PJ, Mosfeghi AA, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging 2005;36:331-5.
2. Tewari A, Dhalla MS, Apte RS. Intravitreal bevacizumab for treatment of choroidal neovascularization in pathologic myopia. Retina 2006;26:1093-4.
3. Shaikh S. Intravitreal bevacizumab (Avastin) for the treatment of proliferative sickle retinopathy. Indian J Ophthalmol 2008;56:259.
4. Kumar A, Sinha S. Intravitreal bevacizumab (Avastin): Treatment of diffuse diabetic macular edema in an Indian population. Indian J Ophthalmol 2007;55:451-5.
5. Iturralde D, Spaide RF, Meyerle CB, Klancnik JM, Yannuzzi LA, Fisher YL, et al. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: A short-term study. Retina 2006;26:279-84.
6. Agarwal M, Dubey S. Intra-cameral injection of Bevacizumab (Avastin) to treat anterior chamber neovascular membrane in a painful blind eye. Indian J Ophthalmol 2008;56:258-9.
7. Available from: http://www.nlm.nih.gov/services/ctphases.html. [last reviewed and updated on 2008 Apr 18,[cited on 2001 Jan 1].
8. Nundy S, Chir M, Gulhati CM. A New colonialism-Conducting clinical trials in India. N Engl J Med 2005;352:1633-36
9. Khamar B. Off label use of medicines: Medical research and medical practice. Indian J Ophthalmol 2007;55:411-2.
10. Radley DC, Finkelstein SN, Stafford RS. Off-label prescribing among office-based physicians. Arch Intern Med 2006;166:1021-6.
11. rd Annual Meeting Sunday June 12, 2004 Grand Ballroom Hyatt Regency Chicago USA.
12. Azad RC, Gupta R. The economic implications of the use of anti-vascular endothelial growth factor drugs in age-related macular degeneration. Indian J Ophthalmol 2007;55:441-3.
13. Gillies MC. What we don't know about avastin might hurt us. Arch Ophthalmol 2006;124:1478-9.